SUBSCRIBE
SUBSCRIBE
News   Business

PharmaPraxis Announces an Agreement with Brazil’s Ministry of Health to Manufacture Monoclonal Antibodies

April 7, 2011 | 
1 min read
RIO DE JANEIRO, Brazil--(BUSINESS WIRE)--PharmaPraxis, from Axis Biotec, Cryopraxis, Silvestre Labs and CellPraxis Group, announces the formalization of an agreement with Brazil's Ministry of Health to manufacture biologic drugs.
Alliances South America
MORE ON THIS TOPIC
Different types of glue on light blue background, flat lay.
Funding
Degron adds $40M to series A, supporting immunology plans for molecular glue platform
May 14, 2026
 · 
2 min read
 · 
Tristan Manalac
Downsizing or layoff employee, contract termination, loss job from redundancy, dismissal workforce, restructure company, unemployed or outsourcing, businessman hand cut job from organization chart.
Layoffs
Takeda’s ‘transformation program’ leaves 4,500 jobless
May 14, 2026
 · 
2 min read
 · 
Tristan Manalac
Aerial view from window plane of San Cristobal at Galapagos island, Ecuador
Earnings
Goodbye Galapagos: chameleon company exits the island, rebrands as Lakefront
May 13, 2026
 · 
2 min read
 · 
Heather McKenzie
FDA
Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay
May 13, 2026
 · 
1 min read
 · 
Heather McKenzie